Maintaining Quality Oversight of Contract Manufacturing Organizations Through Mergers and Acquisitions
Posted on December 19, 2017
Stanley J. Russell, Head of Quality Management Systems and Programs
Shire
Introduction Outsourcing to Contract Manufacturing Organizations (CMOs) is a key element of the business model of 70-90%1 of Pharmaceutical and Biotech companies. These companies derive 15-100%1 of their sales revenues from contract manufactured products. In addition, between 20 and 30 Pharma/Biotec...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Abbott Laboratories, Acquisition and merger, Contract Manufacturing Organizations CMOs, Global Quality Management System, Manufacturing oversight, manufacturing Quality oversight, Outsourcing, Pharma Biotech mergers, product release, product supply, QMS, quality organization, Quality oversight, Stanley J. Russell Stan J Russell
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
